Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial
| Image |  |
|---|---|
| Description | scientific article published on 14 June 2019 |
| Author/s |
author: Rebecca A Gregory Glenn D Flux |
| Publication date | June 14, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |